Search | IOVS | ARVO Journals

Showing 1 – 20 of 23

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2018

Changes in choroidal area after intraocular pressure reduction following trabeculectomy

Kazuyuki Hirooka; Hirokazu Kojima; Eri Nitta; Kaori Ukegawa; Shozo Sonoda; Taiji Sakamoto

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):461. doi:

ARVO Annual Meeting Abstract July 2018

One-year Outcomes of Fixed Treatment of Intravitreal Aflibercept for Exudative Age-related Macular Degeneration and the Factor of Visual Prognosis

Rie Osaka; Chieko Shiragami; Aoi Ono; Saki Manabe; Yukari Takasago; Mamoru Kobayashi; Ayana Yamashita; Kazuyuki Hirooka

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):811. doi:

ARVO Annual Meeting Abstract July 2018

Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization

Chieko Shiragami; Yukari Takasago; Rie Osaka; Mamoru Kobayashi; Aoi Ono; Ayana Yamashita; Kazuyuki Hirooka

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3133. doi:

ARVO Annual Meeting Abstract July 2018

Retinal ganglion cell loss in Alcadein α knockout mice

Yuki Nakano; Aoi Ono; Mamoru Kobayashi; Yukari Takasago; Tohru Yamamoto; Kazuyuki Hirooka

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3706. doi:

ARVO Annual Meeting Abstract July 2018

Relationship between plasma aldosterone concentration and retinal ganglion cell death

Yukari Takasago; Kazuyuki Hirooka; Aoi Ono; Mamoru Kobayashi; Yuki Nakano

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5510. doi:

ARVO Annual Meeting Abstract June 2017

Oxygen saturation of the retinal vessels may differ between primary open-angle glaucoma and normal-tension glaucoma

Kazuyuki Hirooka; Takeru Shimazaki; Yuki Nakano; Eri Nitta; Kaori Ukegawa; Akitaka Tsujikawa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):735. doi:

Physiology and Pharmacology March 2017

The Relationship Between the Renin-Angiotensin–Aldosterone System and NMDA Receptor-Mediated Signal and the Prevention of Retinal Ganglion Cell Death

PDF

Mamoru Kobayashi; Kazuyuki Hirooka; Aoi Ono; Yuki Nakano; Akira Nishiyama; Akitaka Tsujikawa

Invest. Ophthalmol. Vis. Sci.. 2017; 58(3):1397-1403. doi: 10.1167/iovs.16-21001

ARVO Annual Meeting Abstract September 2016

Paravascular Inner Retinal Defects Associated with Epiretinal Membranes

Akitaka Tsujikawa; Yukiko Miyoshi; Saki Manabe; Yuki Nakano; Tomoyoshi Fujita; Chieko Shiragami; Kazuyuki Hirooka; Akihito Uji; Yuki Muraoka

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4053. doi:

ARVO Annual Meeting Abstract September 2016

Retinal Oximetry in a Healthy Japanese Population

Yuki Nakano; Takeru Shimazaki; Nobuko Kobayashi; Yukiko Miyoshi; Aoi Ono; Mamoru Kobayashi; Chieko Shiragami; Kazuyuki Hirooka; Akitaka Tsujikawa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1664. doi:

ARVO Annual Meeting Abstract September 2016

Relationship between oxygen saturation of the retinal vessels and visual field defect in glaucoma patients: comparison with each hemifield

Kazuyuki Hirooka; Takeru Shimazaki; Yuuki Nakano; Eri Nitta; Kaori Ukegawa; Shino Sato; Akitaka Tsujikawa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2988. doi:

ARVO Annual Meeting Abstract September 2016

Metamorphopsia Associated with Branch Retinal Vein Occlusion

Koichiro Manabe; Rie Osaka; Yuki Nakano; Tomoyoshi Fujita; Chieko Shiragami; Kazuyuki Hirooka; Yuki Muraoka; Akihito Uji; Akitaka Tsujikawa

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5335. doi:

ARVO Annual Meeting Abstract June 2015

Estimating the rate of retinal ganglion cell loss to detect glaucoma progression

Kazuyuki Hirooka; Saeko Izumibata; Saki Manabe; Kaori Ukegawa; Eri Nitta; Shino Sato; Akitaka Tsujikawa

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):616. doi:

ARVO Annual Meeting Abstract April 2014

Preoperative intravitreal bevacizumab on trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factor for surgical failure

Kazuyuki Hirooka; Tetsuya Baba; Eri Nitta; Kaori Tenkumo; Shino Sato

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3155. doi:

ARVO Annual Meeting Abstract June 2013

Protective Effects of Renin Inhibitor in Retinal Ischemia-reperfusion Injury

Kazuyuki Hirooka; Kaori Tenkumo; Eri Nitta; Tomoyoshi Fujita; Fumio Shiraga

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):6356. doi:

Glaucoma April 2013

Correlation Between the Ganglion Cell-Inner Plexiform Layer Thickness Measured With Cirrus HD-OCT and Macular Visual Field Sensitivity Measured With Microperimetry

PDF

Shino Sato; Kazuyuki Hirooka; Tetsuya Baba; Kaori Tenkumo; Eri Nitta; Fumio Shiraga
TAGS: glaucoma, ganglia, visual fields, eye
Invest. Ophthalmol. Vis. Sci.. 2013; 54(4):3046-3051. doi: 10.1167/iovs.12-11173

Physiology and Pharmacology June 2012

Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1-R) Blocker via Modulating AT1-R Signaling and Decreased Extracellular Glutamate Levels

PDF

Tomoyoshi Fujita; Kazuyuki Hirooka; Takehiro Nakamura; Toshifumi Itano; Akira Nishiyama; Yukiko Nagai; Fumio Shiraga
TAGS: ischemia, signal transduction, glutamates, retina, candesartan cilexetil, glutamate, receptor, angiotensin, type 1, neuroprotective effect
Invest. Ophthalmol. Vis. Sci.. 2012; 53(7):4099-4110. doi: 10.1167/iovs.11-9167

ARVO Annual Meeting Abstract March 2012

Activation of the Aldosterone/Mineralocorticoid Receptor System and Protective Effects of Mineralocorticoid Receptor Antagonism in Retinal Ischemia- Reperfusion Injury

Kazuyuki Hirooka; Ye Liu; Tomoyoshi Fujita; Fumio Shiraga

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):6409. doi:

ARVO Annual Meeting Abstract March 2012

Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1-R) Blocker via Modulating AT1-R Signaling and Decreased Extracellular Glutamate Levels

Tomoyoshi Fujita; Kazuyuki Hirooka; Fumio Shiraga

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5324. doi:

ARVO Annual Meeting Abstract April 2011

Relationship between Progression of Visual Field Damage and Choroidal Thickness in Eyes with Normal-Tension Glaucoma

Kazuyuki Hirooka; Atsushi Fujiwara; Chieko Shiragami; Tetsuya Baba; Fumio Shiraga

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5083. doi:

Physiology and Pharmacology July 2010

Neuroprotection against Retinal Ischemia–Reperfusion Injury by Blocking the Angiotensin II Type 1 Receptor

PDF

Kouki Fukuda; Kazuyuki Hirooka; Masanori Mizote; Takehiro Nakamura; Toshifumi Itano; Fumio Shiraga
TAGS: captopril, ischemia, retinal ischemia, reperfusion injury, retina, candesartan cilexetil, receptor, angiotensin, type 1
Invest. Ophthalmol. Vis. Sci.. 2010; 51(7):3629-3638. doi: 10.1167/iovs.09-4107

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Changes in choroidal area after intraocular pressure reduction following trabeculectomy

One-year Outcomes of Fixed Treatment of Intravitreal Aflibercept for Exudative Age-related Macular Degeneration and the Factor of Visual Prognosis

Clinical features of central serous chorioretinopathy with type 1 choroidal neovascularization

Retinal ganglion cell loss in Alcadein α knockout mice

Relationship between plasma aldosterone concentration and retinal ganglion cell death

Oxygen saturation of the retinal vessels may differ between primary open-angle glaucoma and normal-tension glaucoma

The Relationship Between the Renin-Angiotensin–Aldosterone System and NMDA Receptor-Mediated Signal and the Prevention of Retinal Ganglion Cell Death

Paravascular Inner Retinal Defects Associated with Epiretinal Membranes

Retinal Oximetry in a Healthy Japanese Population

Relationship between oxygen saturation of the retinal vessels and visual field defect in glaucoma patients: comparison with each hemifield

Metamorphopsia Associated with Branch Retinal Vein Occlusion

Estimating the rate of retinal ganglion cell loss to detect glaucoma progression

Preoperative intravitreal bevacizumab on trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factor for surgical failure

Protective Effects of Renin Inhibitor in Retinal Ischemia-reperfusion Injury

Correlation Between the Ganglion Cell-Inner Plexiform Layer Thickness Measured With Cirrus HD-OCT and Macular Visual Field Sensitivity Measured With Microperimetry

Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1-R) Blocker via Modulating AT1-R Signaling and Decreased Extracellular Glutamate Levels

Activation of the Aldosterone/Mineralocorticoid Receptor System and Protective Effects of Mineralocorticoid Receptor Antagonism in Retinal Ischemia- Reperfusion Injury

Neuroprotective Effects of Angiotensin II Type 1 Receptor (AT1-R) Blocker via Modulating AT1-R Signaling and Decreased Extracellular Glutamate Levels

Relationship between Progression of Visual Field Damage and Choroidal Thickness in Eyes with Normal-Tension Glaucoma

Neuroprotection against Retinal Ischemia–Reperfusion Injury by Blocking the Angiotensin II Type 1 Receptor

To View More...

You must be signed into an individual account to use this feature.